Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis…
Drug Manufacturers - Specialty & Generic
US, Ardsley [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Acorda Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Acorda Therapeutics, Inc. has no acquisition track records yet.